NewInsight: Anthropic's IPO price against 48 tech IPOs since 1997

MiniMed Group MMED

MiniMed Group listed on Nasdaq on 6 Mar 2026 and is not in the S&P 500. It is worth $4.6 billion. Its price history starts on 6 Mar 2026. Its board has 11 directors, 5 of them independent. 5 other officers are on file. At 30 Jun 2026, MFS (Massachusetts Financial Services) was its largest institutional holder, with 3.0% of the company.

CEO
Que Dallara
Chair
Kevin E. Lofton
Listed
6 Mar 2026 on Nasdaq, IPO filings and terms
Headquarters
Northridge, CA
Market cap
$4.6B
19 Nov 2026 close
Revenue
$3.1B
Fiscal year 2026
Price to sales
1.5
Market cap over revenue

Financials

Financial history

Twelve months to 31 Jul 2026, from MiniMed Group's quarterly filings.

Quarters since Jan 2025

P/E
-
No profit over the last four quarters

Quarterly results

Each quarter's revenue, net income and free cash flow.

Jan 2025 to Jul 2026

$0$250M$500M$750M$1B20252026$843M

Revenue breakdown

MiniMed Group's $843M of revenue, as its quarterly report splits it. Parts that are not a business, such as sales between segments, can be negative.

Quarter to Jul 2026

  • CGM$431M, 51.1%
  • Consumables$261M, 31.0%
  • Pumps$144M, 17.1%
  • Other$7M, 0.8%

MiniMed Group's market cap since March 2026

Weekly, up to 13 Nov 2026

Apr 2026MayJunJulAugSepOctNov$5.1B

Board and leadership

Board and officers

2 people here also hold roles at other S&P 500 companies.

Board from the proxy filed 21 Aug 2026; officers filed up to 30 Sep 2026

NameTitleSinceIndependentCommitteesAge
Directors (11)
Kevin E. LoftonChairIndependent 路 since 2026 路 Compensation and Talent, Nominating and Corporate Governance (chair)Former Chief Executive Officer, CommonSpirit HealthAlso at MedtronicChair2026YesCompensation and Talent, Nominating and Corporate Governance (chair)71
Que DallaraChief Executive OfficerNot independent 路 since 2026Other boards: Lattice SemiconductorChief Executive Officer2026No53
Linnea BurmanDirectorNot independent 路 since 2026Senior Vice President and President, Neurovascular, Medtronic plcDirector2026No52
Scott T. CundyDirectorNot independent 路 since 2026 路 Nominating and Corporate GovernanceSenior Vice President and Chief Quality, Development, and Innovation Officer, Medtronic plcDirector2026NoNominating and Corporate Governance56
Glenn A. EisenbergDirectorIndependent 路 since 2026 路 Audit (chair)Special Advisor to Labcorp; Senior Advisor at Rh么ne Group; Former Executive Vice President and Chief Financial Officer, Labcorp Holdings Inc.Also at SolventumOther boards: Lumexa Imaging Holdings and The Middleby CorporationDirector2026YesAudit (chair)65
David J. EndicottDirectorIndependent 路 since 2026 路 Compensation and TalentChief Executive Officer, Alcon, Inc.Other boards: AlconDirector2026YesCompensation and Talent61
D. Keith GrossmanDirectorIndependent 路 since 2026 路 Audit, Nominating and Corporate GovernanceFormer Chair and Chief Executive Officer, Nevro Corp.Other boards: Outset Medical and AlconDirector2026YesAudit, Nominating and Corporate Governance66
Robert (Bob) HopkinsDirectorNot independent 路 since 2026 路 Nominating and Corporate GovernanceSenior Vice President and Head of Global Strategy, Medtronic plcDirector2026NoNominating and Corporate Governance59
Laura MauriDirectorNot independent 路 since 2026 路 Compensation and TalentSenior Vice President, Chief Scientific and Medical Officer, Medtronic plcDirector2026NoCompensation and Talent57
Matthew (Matt) R. WalterDirectorNot independent 路 since 2026 路 Compensation and TalentSenior Vice President of Human Resources, IT and Global Communications and Corporate Marketing, Medtronic plcDirector2026NoCompensation and Talent48
Timothy A. WicksDirectorIndependent 路 since 2026 路 Audit, Compensation and Talent (chair)Former Chief Executive Officer and President, OptumRXOther boards: BrightSpring Health Services and GMR SolutionsDirector2026YesAudit, Compensation and Talent (chair)61
Officers (5)
Chad SpoonerEVP, Chief Financial OfficerLast filed 29 Jul 2026EVP, Chief Financial Officer
Gillian ChandrasenaSVP, Chief HR OfficerLast filed 29 Jul 2026SVP, Chief HR Officer
Ali DianatyEVP Ch. Prod. & Tech OfficerLast filed 4 Aug 2026EVP Ch. Prod. & Tech Officer
Christopher EsoPresidentLast filed 5 Mar 2026President
John GyurciVP, Chief Accounting OfficerLast filed 6 Jul 2026VP, Chief Accounting Officer

Owners and trading

Largest institutional holders

Each fund group's share of MiniMed Group. Where a company has several share classes, the share is of its total value.

13F filings for the quarter to 30 Jun 2026

These five hold 6.8% of MiniMed Group.

Timeline

Leadership changes, layoffs and insider sales

20 Nov 2024 to 20 Nov 2026; insider sales from 19 Nov 2025

7 departures and 19 appointments of directors and officers in the last two years.

Left the company or board 7Appointed 19WARN layoff notices 0Jan 2025AprJulOctJan 2026AprJulOct

Events, newest first

Showing 8 of 26 events

Not on file: no open-market insider buys or sales in the 12 months to 19 Nov 2026, no trades disclosed by members of Congress or officials since November 2023, no WARN layoff notices under its own name or a listed subsidiary's since November 2023, no open roles from its careers site yet and no earnings release figures from the last six months.